Drug Type Autologous CAR-T |
Synonyms Autologous BCMA CAR-T cell(The First Affiliated Hospital of Nanchang University) |
Target |
Mechanism BCMA modulators(B-cell maturation protein modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Refractory Multiple Myeloma | Phase 1 | CN | 01 Dec 2019 | |
Relapse multiple myeloma | Phase 1 | CN | 01 Dec 2019 |